scispace - formally typeset
J

JM Werner

Researcher at National Institutes of Health

Publications -  7
Citations -  305

JM Werner is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Interleukin 21 & Interleukin 12. The author has an hindex of 6, co-authored 7 publications receiving 263 citations.

Papers
More filters
Journal ArticleDOI

Monocytes Activate Natural Killer Cells via Inflammasome-Induced Interleukin 18 in Response to Hepatitis C Virus Replication

TL;DR: Monocytes sense cells that contain replicating HCV and respond by producing interleukin-18 via the inflammasome and by activating NK cells, indicating a role for monocytes in NK cell activation.
Journal ArticleDOI

Innate immune responses in hepatitis C virus-exposed healthcare workers who do not develop acute infection.

TL;DR: Exposure to small amounts of HCV induces innate immune responses, which correlate with the subsequent HCV‐specific T‐cell response and may contribute to antiviral immunity.
Journal ArticleDOI

Durability of Antibody Response Against Hepatitis B Virus in Healthcare Workers Vaccinated as Adults

TL;DR: The rapid and robust response to a booster vaccine suggests a long-lasting amnestic response and Hepatitis B vaccination provides long-term protection against hepatitis B and booster vaccination does not appear to be necessary in HCWs.
Journal ArticleDOI

The hepatitis B vaccine protects re-exposed health care workers, but does not provide sterilizing immunity.

TL;DR: HBs antigen vaccine-induced immunity protects against future infection but does not provide sterilizing immunity, as evidenced by HBcore- and polymerase-specific CD8(+) T cells in vaccinated health care workers with occupational exposure to HBV.
Journal ArticleDOI

Occupational Exposure to Hepatitis C Virus: Early T-Cell Responses in the Absence of Seroconversion in a Longitudinal Cohort Study

TL;DR: Subclinical transmission of HCV occurs frequently, resulting in infection and synthesis of nonstructural proteins despite undetectable systemic viremia and T-cell responses are more sensitive indicators of this low-level HCV exposure than antibodies.